Inspection Record

BGP Pharma ULC — Health Canada Inspection Findings

Health CanadaInspected 2022-11-07 4 findingsOther quality systemLaboratory and QC controlsDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The implementation of a self-inspection program was inadequate.

2Laboratory and QC controls

Confirmatory testing was not performed by an alternate laboratory.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

4Other quality system

The system for reviewing, revising, and approving standard operating procedures was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-11-07. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

BGP Pharma ULC company profile — full history Health Canada documents, 2022 Go to Findings search